Health and care technology company Tunstall Healthcare has appointed Peter Nicklin as chairman.

Nicklin has been a senior healthcare executive with Baxter International, Bayer Healthcare, Novartis and Bristol-Myers Squibb, working across a range of sectors, including pharmaceuticals, biologics, vaccines, medtech, dental, animal health and healthcare services.

More recently, Nicklin was chief executive of Amann Girrbach based in Koblach, Austria. He is currently chairman of Versantis, a Swiss pharmaceutical company, and Healthcare at Home a pharma services company focused on chronic, rare disease and oncology medicine management services.

Nicklin said: “I’m delighted to be joining Tunstall at such a pivotal time for the digitally connected health and social care industry as there is rapid acceleration in the adoption of digital healthcare worldwide. Tunstall is ideally placed to continue to build on its market leading position in the sector throughout the countries it operates. I look forward to working with the Tunstall team to capitalise on opportunities in the market and drive forward its strategy.”